8ALLHAT Collaborative Research Group.Major outcomes in highrisk hypertension patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:The antihypertensive and lipid-lowering treatment to prevent heart attack trial(ALLHAT)[J].J AMA,2002,288:2981-2997.
9The seventh report of the joint national committee on prevention detection evaluation and treatment of high blood pressure (JNCT):Is it really practical[J].Natl Med J India,2004,17(4):227.
10Whitworth JA.World health organization international society of hypertension writing group 2003 world health organization(WHO)/international society of hypertension (ISH) statement on management of hypertension[J].J Hypertens,2003,21 (11):1983-1992.
4Committee G.2003 European society of hypertension-european society of cardiology guidelines for the management of arterial hypertension[J].J Hypertension,2003,21:1011-53.
5The Seventh Report of the Joint National Committee on Prevention,Detection,Evaluation,and Treatment of High Blood Pressure(JNCT):is it really practical[J]?Natl Med J India,2004,17(4):227.
6Whitworth JA:World Health Organization,International Society of Hypertension Writing Group.2003 World Health Organization (WHO) /International Society of Hypertension(ISH) statement on management of hypertension[J].J Hypertens,2003,21(11):1983-92.
8JoelG.Hardman Lee E.Limbird 金有豫主译.Goodman & Gilman’s The Pharmacological Basis of Therapeutics,10/e[M].古德曼吉尔曼治疗学的药理学基础.第10版[M].北京:人民卫生出版社,..
9Guide to Good Prescribing.A Practical Manual.Geneva:World Health Organization;1994.http://www.who.int/medicines/library/par/ggprescribing/who-dap-94-11en.pdf.
10Hill SR,Smith AJ.First-Line medicines in the treatment of hypertension[J].Australian Prescriber,2005,28:34-7.
